New drug may hold promise for lupus sufferers - The Post and Courier
For the first time in a half-century, a new drug appears to offer hope to sufferers of lupus, the chronic, autoimmune disease that plagues an estimated 2 million people, mostly women, in the United States. Benlysta, a drug developed by Human Genome
India refinery ‘threatens health of local community’ - BBC South-Asia
value can cause irritation of the skin, and exposure to water with a pH level of 12 or above can cause blistering or burns. “We used to bathe in the river but now I am scared of taking my children there. Both my sons have had rashes and blisters
Co-existence of chronic renal failure, renal clear cell carcinoma, and - UroToday
due to recurrent uveitis, camptodactyly, and persistent erythematous rash with ichthyosis. Her two sisters and her mother were affected with combinations of these conditions-symmetric polyarthritis, uveitis, and skin involvement-suggesting an
New drug may hold promise for lupus sufferers - The Post and Courier
For the first time in a half-century, a new drug appears to offer hope to sufferers of lupus, the chronic, autoimmune disease that plagues an estimated 2 million people, mostly women, in the United States. Benlysta, a drug developed by Human Genome
India refinery ‘threatens health of local community’ - BBC South-Asia
value can cause irritation of the skin, and exposure to water with a pH level of 12 or above can cause blistering or burns. “We used to bathe in the river but now I am scared of taking my children there. Both my sons have had rashes and blisters
Co-existence of chronic renal failure, renal clear cell carcinoma, and - UroToday
due to recurrent uveitis, camptodactyly, and persistent erythematous rash with ichthyosis. Her two sisters and her mother were affected with combinations of these conditions-symmetric polyarthritis, uveitis, and skin involvement-suggesting an